Literature DB >> 3511560

Hemodynamic determinants of mortality in human septic shock.

A B Groeneveld, W Bronsveld, L G Thijs.   

Abstract

To assess the relative importance of cardiac versus peripheral vascular failure in patients dying of septic shock, a series of 42 patients with documented septic shock was retrospectively evaluated. Patients were included in the study if serial hemodynamic and metabolic studies had been performed: the first one within 12 hours after onset of septic shock and the last one within 12 hours (median 2 hours; range 0.1 to 12 hours) before death in nonsurvivors. Nonsurvivors were included only if they died in shock. From the patient records the first, highest, and last measured cardiac indexes (CI) (t = 1, t = 2, and t = 3) with concomitant hemodynamic and metabolic variables were obtained. Group I (n = 21) consisted of survivors and group II (n = 21) of nonsurvivors. Group II was divided into three subgroups: group IIa (n = 4) consisted of nonsurvivors with liver cirrhosis, group IIb (n = 9) patients with final CI less than 4 1 X min-1 X m-2, and group IIc (n = 8) patients with final CI greater than 4 1 X min-1 X m-2. At t = 1 no significant differences in hemodynamic variables were found between groups I and II, and all patients, whether surviving or not, were able to increase CI to similar levels. At t = 3 group II showed a marked decrease in mean arterial pressure and systemic vascular resistance index compared with group I (p less than 0.001), whereas CI did not differ significantly. The nonsurvivors showed progressive lactic acidemia. Even group IIb patients showed persistent vasodilation despite a decrease in CI. Our data suggest that many patients in septic shock die as a result of peripheral vascular rather than cardiac failure, since persistent vasodilation, irrespective of CI, was a major hemodynamic determinant in nonsurvivors, of whom 57% maintained a high CI until shortly before death.

Entities:  

Mesh:

Year:  1986        PMID: 3511560

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  36 in total

1.  In vivo measurement of nitric oxide production in porcine gut, liver and muscle during hyperdynamic endotoxaemia.

Authors:  Maaike J Bruins; Wouter H Lamers; Alfred J Meijer; Peter B Soeters; Nicolaas E P Deutz
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Early recovery in hemodynamics after direct hemoperfusion with polymyxin B-immobilized fibers may predict mortality rate in patients with septic shock.

Authors:  Atsuko Kobayashi; Yasushi Iwasaki; Yuichi Kimura; Yoshiaki Kawagoe; Yoshihito Ujike
Journal:  J Anesth       Date:  2010-07-17       Impact factor: 2.078

Review 3.  Differential Paradigms in Animal Models of Sepsis.

Authors:  S Manoj Kumar Kingsley; B Vishnu Bhat
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

4.  Peripheral vascular resistance in septic shock: its relation to outcome.

Authors:  A B Groeneveld; J J Nauta; L G Thijs
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

Review 5.  A model for the interplay of inflammatory mediators in sepsis--a study in 48 patients.

Authors:  C E Hack; J H Nuijens; R J Strack van Schijndel; J J Abbink; A J Eerenberg; L G Thijs
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 6.  The haemodynamics of septic shock.

Authors:  L G Thijs; A J Schneider; A B Groeneveld
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

7.  Impaired arterial reactivity following cytomegalovirus infection in the immunosuppressed rat.

Authors:  P H Eerdmans; M C Persoons; S J Debets; H A Struijker Boudier; J F Smits; C A Bruggeman; J G De Mey
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

8.  Abrupt hemodynamic improvement in late septic shock with physiological doses of glucocorticoids.

Authors:  A J Schneider; H J Voerman
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

9.  Proteolytic inactivation of plasma C1- inhibitor in sepsis.

Authors:  J H Nuijens; A J Eerenberg-Belmer; C C Huijbregts; W O Schreuder; R J Felt-Bersma; J J Abbink; L G Thijs; C E Hack
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

10.  Prolonged NO treatment decreases alpha-adrenoreceptor agonist responsiveness in porcine pulmonary artery due to persistent soluble guanylyl cyclase activation.

Authors:  William J Perkins; Susan Kost; Mark Danielson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-01-30       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.